Background: Malignant gliomas are the most common primary tumors in the central nervous system. Methods: We investigated the combined effect of PG490 and LPS on the induction of the apoptotic pathway in human astroglioma cells. Results: Treatment of U87 cells with combination of 50 nM of PG490 and 50 g/ml of LPS resulted in increased internucleosomal DNA fragmentation, cleavage of PLC-1, and downregulation of cIAP1 and XIAP. The combination of LPS and PG490 treatment-induced apoptosis is mediated through the activation of caspase, which is inhibited by the caspase inhibitor, z-VAD-fmk. Also, release of cytochrome c was found in PG490 and LPScotreated U87 cell. Conclusion: Taken together, combination of PG490 and LPS appears to be a potent inducer of apoptosis in astrogliaoma cells, and might have some benefit in the treatment of glioma patients. 
Introduction
LPS is a component of Gram negative bacterial cell walls, which has a biological activity and plays a critical role in immune and inflammatory responses. LPS is a trigger of tumor necrosis factor (TNF)-in the central nerve system and induces apoptosis in the rat brain (1) . In human neuroblastoma SH-SY5Y cells, S-nitroso-N-acetylpenicillamine (SNAP), a nitric oxide (NO)-donor, caused cell death accompanying nucleosomal DNA fragmentation (2) . Also, LPS induced the secretion of TNF-and the production of nitric oxide in mouse macrophages (3) . Treatment with shiga toxin 1 (Stx1) and LPS resulted in the rapid onset of cell death compared to LPS alone treatment, indicating a slightly faster induction of cell death in combination of Stx1 and LPS-treated cells (4) . We hypothesized that the combined treatment with LPS as an apoptotic trigger and a chemotherapeutic agent would increase cell death activity compared with single-agent treatment.
PG490 (triptolide) is a diterpenoid triepoxide compound derived from Chinese herb Tripterygium wilfordii Hook F, which possesses potent anti-inflammatory and immunosuppressive properties (5, 6) . Recent studies show that triptolide inhibits mitogen-induced lymphocyte proliferation and has immunosuppressive effects in skin allograft transplantation (7, 8) . Further reports demonstrate that triptolide possesses antiproliferative activity against L1210 and P388 mouse leukemia cells and suppresses colony formation of breast cancer cell lines (9, 10) . Also, previous studies have shown that PG490, immunomodulating agent, enhances chemotherapy-induced apoptosis (11) (12) (13) .
The current study was designed to investigate a combinatory cytotoxic effect of PG490 and LPS on human glioma cells. Therefore, we examined the mechanism of antitumor activity of combined PG490 and LPS in human glioblastoma cells. We have shown that combination of PG490 and LPS-induced apoptosis is mediated by caspase-3 activation and down-regulation of cIAP1 and XIAP.
obtained from the American Type Culture Collection (ATCC). Cells were cultured in DMEM supplement with 10% fetal bovine serum, 100 units/ml penicillin, and 100 g/ml streptomycin (Gibco). PG490 (Alexis) and LPS (Sigma-Aldrich) was directly added to cell cultures at the indicated concentrations. Anti-cIAP1, anti-cIAP2, anti-Bcl-2, anti-Bcl-xL, anti-Bax, anti-cytochrome c, and anti-HSP70 antibodies were purchased from Santa Cruz Biotechnology Inc. Antibodies against specific proteins were obtained from the following suppliers: XIAP from R&D systems, and benzyloxycarbony-Val-Ala-Asp-fluoromethyl ketone (z-VADfmk) from Biomol. Western blotting. Cellular lysates were prepared by suspending 1.5×10 6 cells in 100 l of lysis buffer (137 mM NaCl, 15 mM EGTA, 0.1 mM sodium orthovanadate, 15 mM MgCl 2 , 0.1% Triton X-100, 25 mM MOPS, 100 M phenylmethylsulfonyl fluoride, and 20 M leupeptin, adjusted to pH 7.2). The cells were disrupted by sonication and extracted at 4 o C for 30 min. Proteins were electrotransferred to Immobilon-P membranes (Millipore Corporation). Specific proteins were detected with an ECL Western blotting kit, according to the manufacturer s instructions. DNA fragmentation assay. After treatment with drugs, U87 cells were lysed in buffer containing 10 mM Tris (pH 7.4), 150 mM NaCl, 5 mM EDTA, and 0.5% Triton X-100 for 30 min on ice. Lysates were vortexed and cleared by centrifugation at 10,000 g for 20 min. Fragmented DNA in the supernatant was extracted with an equal volume of neutral phenol: chloroform:isoamyl alcohol mixture (25 24 1), and analyzed electrophoretically on 2% agarose gels containing 0.1 g/ml ethidium bromide. Caspase-3 activity assay. To evaluate caspase-3 activity, cell lysates were prepared following treatment with LPS and triptolide. Assays were performed in 96-well microtitre plates by incubating 20 g cell lysates in Cleaved PLC-γ1 100 l reaction buffer (1% NP-40, 20 mM Tris-HCl, pH 7.5, 137 mM NaCl, 10% glycerol) containing 5 M DEVD-pNA (a caspase-3 substrate). Lysates were incubated at 37 o C for 2 hr. Absorbance at 405 nm was measured with a spectrophotometer. Analysis of cytochrome c release. Cells (2×10 6 ) were harvested, washed once with ice-cold phosphate buffered saline, and gently lysed for 2 min in 80 l ice-cold lysis buffer (250 mM sucrose, 1 mM EDTA, 20 mM Tris-HCl, pH 7.2, 1 mM DTT, 10 mM KCl, 1.5 mM MgCl 2 , 5 g/ml pepstatin A, 10 g/ml leupeptin, and 2 g/ml aprotinin). Lysates were centrifuged at 12,000 g at 4 o C for 10 min to obtain the supernatants (cytosolic extracts free of mitochondria) and the pellets (fraction that contains mitochondria).
Results

Caspase mediates PG490 and LPS-induced apoptosis.
We investigated the effect of PG490 and LPS on DNA fragmentation in U87 cells to examine the mechanism of cell death. Whereas LPS or PG490 alone did not caused DNA fragmentation, co-treatment with subcytotoxic concentration of 50 nM of PG490 and 50 g/ml of LPS resulted in chromosomal DNA degradation at internucleosomal linkages (Fig. 1A) . These results indicated that the combined PG490 and LPS treatment significantly increased apoptosis in U87 cells. To determine the roles of caspase in PG490 and LPS-induced apoptosis, we measured the activity of caspase-3 in U87 cells treated with combination of PG490 and LPS. Caspase-3 is activated by proteolytic processing of the 32-kDa form into two smaller subunits. Caspase-3 activity during PG490 and LPSinduced apoptosis was determined by measuring proenzyme levels using Western blot analysis. As shown in Fig. 1B , cotreatment with PG490 and LPS for 24 hr resulted in a decrease in pro-caspase-3 levels. To further quantify the proteolytic activity of caspase-3, we performed an in vitro assay, based on the cleavage of DEVD-pNA by caspase-3 into chromophore p-nitroanilide (pNA). U87 cells displayed a 2.3-fold increase in DEVD-pNA cleavage after 24 hr exposure to combination of PG490 and LPS compare to LPS or PG490 single treatment (Fig. 1C) .
Caspase-3 is one of the key proteases responsible for the cleavage of poly (ADP-ribose) polymerase (PARP), PLC-1, DNA-dependent protein kinase, protein kinase C-(PKC-) and Bax, among other substrates (14) (15) (16) . PLC-1 is cleaved into a 60-kDa fragment by in vivo activated caspase-3 (17) . Subsequent Western blotting disclosed proteolytic cleavage of PLC-1 and Bax (Fig. 1B and Fig. 2B ). Cytochrome c release was potentiated by co-treatment of LPS and PG490 in U87 cells after 24 hr (Fig. 1D) .
Modulation of IAP and Bcl-2 protein families in LPS and PG490-induced apoptosis.
To determine whether caspase-3 activity in PG490 and LPS-induced apoptosis is associated with the expression levels of caspase inhibitory proteins and Bcl-2 family proteins, we examined the expression of IAP and bcl-2 family proteins in U87 cells treated with PG490 and LPS. As shown in Fig. 2A , treatment of U87 cells with PG490 and LPS for 24 hr resulted in decreased levels of cIAP1 and XIAP, but not cIAP2. A combined treatment does not significantly alter the expression of the Bcl-2 and Bcl-xL. Interestingly, only Bax pro- tein was slightly cleaved in PG490 and LPS-exposed cells (Fig. 2B ). These data indicate that elevated caspase-3 activity in PG490 and LPS-treated U87 cells is correlated to down-regulation of cIAP1 and XIAP and cleaved Bax protein.
Effects of z-VAD-fmk on LPS and PG490-induced caspase-3 activation.
We examined the consequences of LPS and PG490 treatments on caspase activation in U87 cells treated with a general and potent inhibitor of caspases, z-VAD-fmk. LPS and PG490 strongly stimulated PLC-1 cleavage, caspase-3 protease activity, down-regulation of cIAP1 and XIAP, and Bax cleavage, which were abolished in cells pretreated with z-VAD-fmk (Fig. 3) . These results demonstrated that PG490 and LPS-induced apoptosis was mediated by activation of caspase-3.
Discussion
A combination of an immunomodulating agent with an anticancer drug could improve the tumorcidal effect. Previous studies have shown that PG490, immunomodulating agent, enhances chemotherapy-induced apoptosis (11) (12) (13) . Lee et al. (18) demonstrated that a compound that blocks TNF--induced activation of NF-B may enhance the cytotoxicity of TNF-on tumors in vivo. Hui AM et al reported that suppression of NF-B activation markedly enhances SERM-induced apoptosis, suggesting a role for NF-B in protecting glioma cells (19) . In our previous studies, we have shown PG490 induced apoptosis in human leukemia U937 cells and blocked NF-B signaling pathway in Raw 264.7 macrophage cells (20, 21) .
LPS affects a wide range of physiological functions in the central nervous system (CNS). In previous studies, it had been shown that LPS caused cell death in tyrosine hydroxylase-positive neurons in mixed neuron/glia cultures (22, 23) . Neuronal apoptosis occurring in neuronal degeneration during inflammation can be mediated by TNF-secreted by microglia (1). Whereas, Cheng YJ et al reported enhancement of TNF-expression does not trigger apoptosis upon exposure of glial cells to lead and lipopolysaccharide in human glioma U-373MG cells (24) . Bhat NR et al reported that the treatment of glial cells with either LPS alone (microglia) or a combination of LPS and interferon-gamma (astrocytes) resulted in an induced production of NO and TNF- (25) . Therefore, we hypothesized that combination of TNF-and NO inducer as an apoptotic cell death trigger and immunomodulating agent could have stronger antitumor activity than single agent. 
Procaspase-3
Here, we demonstrated that the combination of LPS and PG490 had a significantly increased cytotoxic activity over that of PG490 or LPS alone in glioma cells. Under the same conditions, PG490 or LPS by itself was not cytotoxic to these cell lines. Also, we have shown that combination of PG490 and LPS treatment induces apoptosis in association with the activation of caspase-3, cleavage of Bax protein, and down-regulation of cIAP1 and XIAP. Recent studies have identified caspases as important mediators of apoptosis induced by various apoptotic stimuli (26) . Caspase-3 is an important cell death-inducing protease that cleaves PARP, PLC-1, and other vital proteins (17, 27, 28) . In our experiments, PG490 and LPS induced caspase-3 activation and PLC-1 cleavage in association with apoptosis (Fig. 1) . Panichakul et al. (12) reported the combined TNF-and PG490 treatment induces apoptosis which is mediated through caspase-3 activation in cholangiocarcinoma.
Additionally, we found that inhibition of caspase activation by z-VAD-fmk prevents LPS and PG490-induced apoptosis (Fig. 3) . The cleavage of PLC-1 was inhibited when the cells were pretreated with caspase inhibitor z-VAD-fmk, suggesting that apoptosis induced by the combination of LPS and PG490 involved activation of caspase-3.
Next, we examined the expression level of IAP and Bcl-2 proteins families, which are possible causes for caspase-3 activation in LPS and PG490-cotreated U937 cells. Human IAP proteins, including XIAP, cIAP1, cIAP2, and survivin, are characterized by the presence of one to three copies of the BIR domain, a 70-amino acid motif that bears homology to sequences found in the baculovirus IAP proteins (29) . These proteins reportedly block apoptosis due to their function as direct inhibitors of activated effector caspases (caspase-3 and caspase-7). Especially, cIAP1 and cIAP2 inhibit cytochrome c-induced activation of caspase-9 (30,31). The Bcl-2 gene family is composed of a group of related genes that either promote or prevent apoptosis (32) . Members of the family include genes such as Bcl-2 or Bcl-xL, which are antiapoptotic, and Bax, which is proapoptotic. Members of the Bcl-2 family of proteins are associated with the mitochondrial membrane and regulate its integrity (32) . In our experiments, only proapoptotic Bax protein was cleaved in LPS-treated or combined PG490 and LPS-treated U87 cells, but the other Bcl-2 protein family level did not affected by PG490 and LPS only or combined LPS and PG490 (Fig. 2) . The combined PG490 and LPS-induced cleavage of Bax protein and down-regulation of cIAP1 and XIAP were inhibited by caspase inhibitor, indicating that the elevated caspase-3 activity in PG490 and LPS-treated U87 is correlated with Bax cleavage and down-modulation of cIAP1 and XIAP proteins.
Persistent activation of NF-B by 10ng/ml of LPS led to the survival of leukemic cells against etoposide (VP16)-induced apoptosis and part of the anti-apoptotic potential of LPS might be caused by NF-B activation (33) . LPS-pretreated cells had lower activity of caspase-3 than cells treated with VP16 alone. In our system, LPS-treated U87 cells showed increased caspase-3 activity (Fig. 1) .
LPS is known to block TNF--induced apoptosis (34, 35) . Both TNF-and LPS activate the NF-B, but through pathways consisting of dissimilar steps. For example, the inhibitory subunit of NF-B, I B , is more profoundly affected by LPS than by TNF-, whereas I B is affected equally by both agents (36, 37) . These mean that NF-B activation can promote apoptosis or survival, depending on the cellular contents. However, how this transcription factor might contribute to the apoptotic process has remained elusive. Further studies will have to be done to elucidate involvement of NF-B signaling pathway. In summary, we have shown that combination of PG490 and LPS-induced apoptosis was at least in part dependent on caspase-3 activation, PLC-1 cleavage, increased caspase-3 activity, and down-regulation of cIAP1 and XIAP.
